Adaptaquin是一种高效的缺氧诱导因子脯氨酰羟化酶 2 (HIF-PHD2) 抑制剂。它通过抑制脂质过氧化并维持线粒体功能,保护细胞免受氧化应激损伤。Adaptaquin 在研究缺氧相关疾病和线粒体功能障碍领域具有潜在应用价值。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | HIF ↓ ↑ | HIF1 ↓ ↑ | PHD1 ↓ ↑ | PHD2 ↓ ↑ | PHD3 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KC7F2 |
+
HIF-1α, IC50: 20 μM |
+
HIF-1α, IC50: 20 μM |
98% | ||||||||||||||||
| Roxadustat | ✔ | 98+% | |||||||||||||||||
| Lificiguat | ✔ | 99%+ | |||||||||||||||||
| BAY 87-2243 | ✔ | 99%+ | |||||||||||||||||
| PX-478·2HCl | ✔ | 98%+ | |||||||||||||||||
| 2-Methoxyestradiol | ✔ | 98% | |||||||||||||||||
| LW6 |
++
HIF, IC50: 4.4 μM |
BCRP | 99%+ | ||||||||||||||||
| Daprodustat | ✔ | 98+% | |||||||||||||||||
| DMOG | ✔ | 98% | |||||||||||||||||
| FG 2216 |
++
PHD2, IC50: 3.9 μM |
99%+ | |||||||||||||||||
| IOX2 |
+++
PHD2, IC50: 21 nM |
99% | |||||||||||||||||
| Molidustat |
++
PHD1, IC50: 480 nM |
+++
PHD2, IC50: 280 nM |
+++
PHD3, IC50: 450 nM |
98+% | |||||||||||||||
| MK-8617 |
++++
PHD1, IC50: 1 nM |
++++
PHD2, IC50: 1 nM |
++++
PHD3, IC50: 14 nM |
99%+ | |||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Adaptaquin is an inhibitor of HIF-PHD2 with an IC50 of 2 μM. It can inhibit lipid peroxidation and preserve mitochondrial function[1][2]. |
| Concentration | Treated Time | Description | References | |
| immortalized striatal neuroblasts (Q7 cells) | 0.25–10 mM | 24 h | To investigate the protective effects of adaptaquin against hemin-induced toxicity. Adaptaquin significantly reduced neuronal death in all three cell types, with EC50 values of 34.1 µM in primary cortical neurons, 50.8 µM in HT22 cells, and 26.7 µM in Q7 cells | Sci Transl Med. 2016 Mar 2;8(328):328ra29 |
| HT-22 cells | 2 μM | 15 h | Adaptaquin inhibits HIF-PHDs, preventing glutamate-induced oxidative stress and cell death, and maintains mitochondrial function. | Cell Death Dis. 2016 May 5;7(5):e2214 |
| Ventral midbrain dopaminergic (VM DA) neurons | 0.5 μM | 24 h | To evaluate the neuroprotective potential of Adaptaquin against 6-OHDA and MPP+-induced dopaminergic neuron death. Results showed that 0.5 μM Adaptaquin significantly protected dopaminergic neurons from the toxicity of 6-OHDA and MPP+. | Neurobiol Dis. 2020 Mar;136:104725 |
| Neuronal PC12 cells | 0.5 μM | 48 h | To evaluate the neuroprotective potential of Adaptaquin against MPP+-induced cell death. Results showed that 0.5 μM Adaptaquin significantly increased cell survival and reduced the formation of intracellular vacuoles. | Neurobiol Dis. 2020 Mar;136:104725 |
| Neuronal PC12 cells | 0.1 μM, 0.5 μM, 1 μM, 5 μM | 24 h | To evaluate the neuroprotective potential of Adaptaquin against 6-OHDA-induced cell death. Results showed that 0.5 μM and higher concentrations of Adaptaquin significantly protected PC12 cells from 6-OHDA-induced cell death and preserved cell morphology. | Neurobiol Dis. 2020 Mar;136:104725 |
| Schwann cells | 10 μM | 16 h | Induction of hypoxia-related adaptive responses, including increased expression of HIF-1α and its target genes | Glia. 2023 Mar;71(3):648-666 |
| rat Schwann cells | 10 μM | 16 h | To evaluate the effect of Adaptaquin on HIF-1α stabilization and HIF-1α target gene transcriptional activity in Schwann cells. Results showed that Adaptaquin significantly increased HIF-1α stabilization and HIF-1α target gene transcriptional activity. | Glia. 2021 Sep;69(9):2215-2234 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Collagenase-induced ICH model | Intraperitoneal injection | 30 mg/kg | Once daily for 7 days | To evaluate the effect of adaptaquin on functional recovery after ICH, results showed that adaptaquin significantly improved sensorimotor function and reduced neuronal degeneration | Sci Transl Med. 2016 Mar 2;8(328):328ra29 |
| C57BL/6 mice | 6-OHDA-induced Parkinson’s disease model | Intraperitoneal injection | 30 mg/kg | Once daily for 7 days | To evaluate the protective effects of Adaptaquin on 6-OHDA-induced death of substantia nigra dopaminergic neurons and striatal TH immunoreactivity. Results showed that Adaptaquin significantly increased the survival of dopaminergic neurons in the substantia nigra and partially restored TH immunoreactivity in the striatum. Additionally, Adaptaquin significantly improved motor function. | Neurobiol Dis. 2020 Mar;136:104725 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.65mL 0.53mL 0.26mL |
13.23mL 2.65mL 1.32mL |
26.47mL 5.29mL 2.65mL |
|
| CAS号 | 385786-48-1 |
| 分子式 | C21H16ClN3O2 |
| 分子量 | 377.82 |
| SMILES Code | OC1=C2N=CC=CC2=CC=C1C(C3=CC=C(Cl)C=C3)NC4=NC=CC=C4O |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | KKYHNYRUBSYTCZ-UHFFFAOYSA-N |
| Pubchem ID | 3740671 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(277.91 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1